This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Nagoya University. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Daisuke Uemura: Innovator in Cyclic Heptapeptide Research
Introduction
Daisuke Uemura is a prominent inventor based in Nagoya, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of novel cyclic heptapeptides. His work focuses on the potential applications of these compounds in medical and health-related fields.
Latest Patents
Daisuke Uemura holds a patent for a cyclic heptapeptide, which is described as a preadipocyte differentiation-inhibitory agent and an adipocyte fat accumulation-inhibitory agent. This innovative cyclic heptapeptide is represented by a specific formula and offers promising applications in the treatment of obesity and related conditions. He has 1 patent to his name.
Career Highlights
Uemura is affiliated with Nagoya University, where he conducts his research and contributes to the academic community. His work has garnered attention for its potential impact on health and wellness, particularly in the area of fat metabolism.
Collaborations
Daisuke Uemura has collaborated with notable colleagues, including Kenichiro Shimokawa and Yoshiaki Iwase. These partnerships have enhanced his research efforts and contributed to the advancement of knowledge in his field.
Conclusion
Daisuke Uemura is a key figure in the development of cyclic heptapeptides, with a focus on their applications in health. His innovative research at Nagoya University continues to pave the way for future advancements in biochemistry and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile